• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁香酚及其衍生物对结核分枝杆菌、非结核分枝杆菌和其他细菌的活性。

Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria.

机构信息

Postgraduate Program in Bioscience & Physiopathology, Department of Clinical Analysis & Biomedicine, State University of Maringa, Parana, Brazil.

Laboratory of Medical Bacteriology, Department of Clinical Analysis & Biomedicine, State University of Maringa, Parana, Brazil.

出版信息

Future Microbiol. 2019 Mar;14:331-344. doi: 10.2217/fmb-2018-0333. Epub 2019 Feb 13.

DOI:10.2217/fmb-2018-0333
PMID:30757916
Abstract

AIM

To evaluate (i) the in vitro activity of eugenol (EUG) and three derivatives against Mycobacterium tuberculosis (Mtb), nontuberculous mycobacteria (NTM) and other bacteria, (ii) the EUG and antituberculosis drugs combinatory effect and (iii) the EUG and its derivatives cytotoxicity.

MATERIALS & METHODS: Minimum inhibitory concentration of the compounds were determined by resazurin microtiter or broth microdilution assay and the drug interaction between EUG and antituberculosis drugs by resazurin drug combination microtiter. The cytotoxicity was carried out in macrophages, HeLa and VERO cells. Results: EUG and derivatives displayed activity and synergic effect of EUG combined with rifampicin, isoniazid, ethambutol, and pyrazinamide in Mtb including multidrug-resistant isolates, with more selectivity to bacillus than macrophages, HeLa and VERO cells (selective index from 0.65 to 31.4). EUG derivatives (4-allyl-2-methoxyphenyl acetate, 4-allyl-2-methoxyphenyl benzoate, and 4-allyl-2-methoxyphenyl 4-nitrobenzoate) were more active against nontuberculous mycobacteria than EUG. EUG and derivatives exhibited low activity in other Gram-positive and -negative bacteria.

CONCLUSION

EUG and its derivatives show activity against Mycobacterium spp. and synergic effect of EUG combined with antituberculosis drugs against Mtb.

摘要

目的

(i)评估丁香酚(EUG)及其三种衍生物对结核分枝杆菌(Mtb)、非结核分枝杆菌(NTM)和其他细菌的体外活性;(ii)EUG 与抗结核药物联合作用;(iii)EUG 及其衍生物的细胞毒性。

材料与方法

采用 Resazurin 微量肉汤稀释法测定化合物的最小抑菌浓度,采用 Resazurin 药物联合微量稀释法测定 EUG 与抗结核药物的相互作用。在巨噬细胞、HeLa 和 VERO 细胞中进行细胞毒性实验。

结果

EUG 及其衍生物对 Mtb(包括耐多药株)具有活性和协同作用,与利福平、异烟肼、乙胺丁醇和吡嗪酰胺联合使用时,对杆菌的选择性高于巨噬细胞、HeLa 和 VERO 细胞(选择性指数为 0.65 至 31.4)。EUG 衍生物(4-烯丙基-2-甲氧基苯基乙酸酯、4-烯丙基-2-甲氧基苯基苯甲酸酯和 4-烯丙基-2-甲氧基苯基 4-硝基苯甲酸酯)对非结核分枝杆菌的活性高于 EUG。EUG 及其衍生物对其他革兰氏阳性和阴性菌的活性较低。

结论

EUG 及其衍生物对分枝杆菌属具有活性,EUG 与抗结核药物联合使用对 Mtb 具有协同作用。

相似文献

1
Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria.丁香酚及其衍生物对结核分枝杆菌、非结核分枝杆菌和其他细菌的活性。
Future Microbiol. 2019 Mar;14:331-344. doi: 10.2217/fmb-2018-0333. Epub 2019 Feb 13.
2
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.一类新型异烟酰腙单独及与异烟肼、利福平、乙胺丁醇、对氨基水杨酸和氯法齐明联合使用对结核分枝杆菌的活性。
J Antimicrob Chemother. 2002 Feb;49(2):275-82. doi: 10.1093/jac/49.2.275.
3
3,5-dinitrobenzoylhydrazone derivatives as a scaffold for antituberculosis drug development.3,5-二硝基苯甲酰腙衍生物作为抗结核药物开发的骨架
Future Microbiol. 2022 Mar;17:267-280. doi: 10.2217/fmb-2021-0119. Epub 2022 Feb 15.
4
Essential oil of is active against mycobacteria.是具有抗分枝杆菌活性的精油。
Future Microbiol. 2023 Jan;18:107-116. doi: 10.2217/fmb-2022-0142. Epub 2023 Jan 20.
5
In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.胡椒碱与抗结核药物在结核分枝杆菌中的体外联合活性。
Tuberculosis (Edinb). 2018 Jul;111:35-40. doi: 10.1016/j.tube.2018.05.006. Epub 2018 May 14.
6
In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis.DNF-3 对耐药结核分枝杆菌的体外活性。
Int J Antimicrob Agents. 2019 Jul;54(1):69-74. doi: 10.1016/j.ijantimicag.2019.02.013. Epub 2019 Feb 23.
7
Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH.(-)-莰烯衍生物在酸性 pH 下对结核分枝杆菌的活性。
Med Chem. 2021;17(5):485-492. doi: 10.2174/1573406415666191106124016.
8
Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.加纳肺结核患者中非结核分枝杆菌的分离与鉴定
Int J Mycobacteriol. 2017 Jan-Mar;6(1):70-75. doi: 10.4103/2212-5531.201895.
9
Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.酰亚胺-β-咔啉和羧酸甲酯-β-咔啉衍生物的合成及抗结核分枝杆菌活性。
Eur J Med Chem. 2020 Feb 1;187:111935. doi: 10.1016/j.ejmech.2019.111935. Epub 2019 Dec 4.
10
Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.新型喹唑啉-4(3H)-酮衍生物的合成与评价,作为抗多药耐药金黄色葡萄球菌和结核分枝杆菌的有效抗菌剂。
Eur J Med Chem. 2019 Aug 1;175:287-308. doi: 10.1016/j.ejmech.2019.04.067. Epub 2019 Apr 28.

引用本文的文献

1
Optimization of Eugenol, Camphor, and Terpineol Mixture Using Simplex-Centroid Design for Targeted Inhibition of Key Antidiabetic Enzymes.使用单纯形重心设计优化丁香酚、樟脑和萜品醇混合物以靶向抑制关键抗糖尿病酶
Curr Issues Mol Biol. 2025 Jul 2;47(7):512. doi: 10.3390/cimb47070512.
2
From clove oil to bioactive agents: synthetic routes, antimicrobial and antiparasitic activities of eugenol derivatives.从丁香油到生物活性剂:丁香酚衍生物的合成路线、抗菌和抗寄生虫活性。
Future Med Chem. 2024;16(20):2169-2188. doi: 10.1080/17568919.2024.2419376. Epub 2024 Oct 30.
3
Efficient Improvement of Eugenol Water Solubility by Spray Drying Encapsulation in Soluplus and Lutrol F 127.
通过在Soluplus和Lutrol F 127中喷雾干燥包封有效提高丁香酚的水溶性
Pharmaceuticals (Basel). 2024 Aug 31;17(9):1156. doi: 10.3390/ph17091156.
4
Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.利用可再利用药物和天然产物中的潜在先导化合物来应对非结核分枝杆菌。
Curr Top Med Chem. 2024;24(15):1291-1326. doi: 10.2174/0115680266276938240108060247.
5
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.用于结核病治疗的先进药物输送和治疗策略。
J Nanobiotechnology. 2023 Nov 9;21(1):414. doi: 10.1186/s12951-023-02156-y.
6
Nature-Inspired Compounds: Synthesis and Antibacterial Susceptibility Testing of Eugenol Derivatives against Strains.受自然启发的化合物:丁香酚衍生物对菌株的合成及抗菌药敏试验
Pharmaceuticals (Basel). 2023 Sep 18;16(9):1317. doi: 10.3390/ph16091317.
7
Antimycobacterial Activity of against and Non-Tuberculous Mycobacteria.[具体物质]对结核分枝杆菌和非结核分枝杆菌的抗分枝杆菌活性
Antibiotics (Basel). 2023 Apr 29;12(5):833. doi: 10.3390/antibiotics12050833.
8
Multi-drug loaded eugenol-based nanoemulsions for enhanced anti-mycobacterial activity.用于增强抗分枝杆菌活性的载有多种药物的丁香酚基纳米乳液。
RSC Med Chem. 2023 Jan 19;14(3):433-443. doi: 10.1039/d2md00320a. eCollection 2023 Mar 22.
9
Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol.整合网络药理学和计算机模拟分析确定了丁香酚对新型冠状病毒奥密克戎变异株的潜在作用。
Heliyon. 2023 Mar;9(3):e13853. doi: 10.1016/j.heliyon.2023.e13853. Epub 2023 Feb 18.
10
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.抗分枝杆菌小分子药物研发管道:再利用药物和有前途的新型化学实体。
Med Res Rev. 2021 Jul;41(4):2350-2387. doi: 10.1002/med.21798. Epub 2021 Mar 1.